Overweight, obesity, and risk of age-related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 57, Issue 3, 2016, Pages 1276-1283

  Zhang, Qian Yu ^a,b   Tie, Li Jun ^a   Wu, Shan Shan ^c   Lv, Pei Lin ^a   Huang, Hong Wei ^b   Wang, Wei Qing ^b   Wang, Hui ^d   Ma, Le ^a,b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d Department of Teaching and Scientific Research of Ideological and Political Theory Course   (China)

Author keywords

Age related macular degeneration; Body mass index; Obesity; Overweight

Indexed keywords

AGE RELATED MACULAR DEGENERATION; ARTICLE; BODY MASS; DISEASE ASSOCIATION; EYE FUNDUS; FOLLOW UP; HUMAN; META ANALYSIS; OBESITY; PRIORITY JOURNAL; PUBLICATION; RISK; SENSITIVITY ANALYSIS; SMOKING; UNITED STATES; COMPLICATION; HEALTH; INCIDENCE; MACULAR DEGENERATION; RISK FACTOR;

BODY MASS INDEX; GLOBAL HEALTH; HUMANS; INCIDENCE; MACULAR DEGENERATION; OBESITY; OVERWEIGHT; RISK FACTORS;

EID: 84962539444     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.15-18637     Document Type: Article

References (44)

1. Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet. 2012;379:1728-1738.
2. Ferris FL III, Wilkinson CP, Bird A, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013; 120:844-851.
3. Vision 2020. The Right to Sight. Global initiative for the elimination of avoidable blindness: action plan 2006-2011. Geneva: World Health Organization. 2007:1-2. Available at: http://apps.who.int/iris/handle/10665/43754. Accessed April 24, 2015.
4. Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:106-116.
5. Nazari H, Zhang L, Zhu D, et al. Stem cell based therapies for age-related macular degeneration: the promises and the challenges. Prog Retin Eye Res. 2015;48:1-39.
6. Boddu S, Lee MD, Marsiglia M, Marmor M, Freund KB, Smith RT. Risk factors associated with reticular pseudodrusen versus large soft drusen. Am J Ophthalmol. 2014;157:985-993.
7. Curcio CA. Complementing apolipoprotein secretion by cultured retinal pigment epithelium. Proc Natl Acad Sci U S A. 2011;108:18569-18570.
8. Després JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012;126:1301-1313.
9. Haas P, Kubista KE, Krugluger W, Huber J, Binder S. Impact of visceral fat and pro-inflammatory factors on the pathogenesis of age-related macular degeneration. Acta Ophthalmol. 2015; 93:533-538.
10. Tokarz P, Kaarniranta K, Blasiak J. Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD). Biogerontology. 2013;14:461-482.
11. Johnson EJ. Obesity, lutein metabolism, and age-related macular degeneration: a web of connections. Nutr Rev. 2005;63:9-15.
12. Bovier ER, Lewis RD, Hammond BR. The relationship between lutein and zeaxanthin status and body fat. Nutrients. 2013;5:750-757.
13. Mares JA, Voland RP, Sondel SA. Healthy lifestyles related to subsequent prevalence of age-related macular degeneration. Arch Ophthalmol. 2011;129:470-480.
14. Schaumberg DA, Christen WG, Hankinson SE, Glynn RJ. Body mass index and the incidence of visually significant age-related maculopathy in men. Arch Ophthalmol. 2001;119:1259-1265.
15. Lechanteur YT, van de Ven JP, Smailhodzic D, et al. Genetic, behavioral, and sociodemographic risk factors for second eye progression in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2012;53:5846-5852.
16. Buch H, Vinding T, la Cour M, Jensen GB, Prause JU, Nielsen NV. Age-related maculopathy: a risk indicator for poorer survival in women: the Copenhagen City Eye Study. Ophthalmology. 2005;112:305-312.
17. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894: 1-253.
18. Cochrane Collaboration; Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Chichester, England, Hoboken, NJ: Wiley-Blackwell; 2008.
19. Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed April 29, 2015.
20. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose response data, with applications to meta-analysis. Am J Epidemiol. 1992;135:1301-1309.
21. Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Metaanalysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 2012;175:66-73.
22. Liu Q, Cook NR, Bergstr¨om A, Hsieh C. A two-stage hierarchical regression model for meta-analysis of epidemiologic nonlinear dose-response data. Comput Stat Data Anal. 2009;53:4157-4167.
23. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ. 1997;315: 629-634.
24. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50: 1088-1101.
25. Tan JS, Mitchell P, Smith W, Wang JJ. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology. 2007; 114:1143-1150.
26. Klein R, Klein BE, Tomany SC, Cruickshanks KJ. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 2003;110:1273-1280.
27. Seddon JM, Reynolds R, Yu Y, Daly MJ, Rosner B. Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. Ophthalmology. 2011;118:2203-2211.
28. Seddon JM, Cote J, Davis N, Rosner B. Progression of agerelated macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol. 2003;121:785-792.
29. Maury E, Nöel L, Detry R, Brichard SM. In vitro hyperresponsiveness to tumor necrosis factor-alpha contributes to adipokine dysregulation in omental adipocytes of obese subjects. J Clin Endocrinol Metab. 2009;94:1393-1400.
30. Kurokawa J, Arai S, Nakashima K, et al. Macrophage-derived AIM is endocytosed into adipocytes and decreases lipid droplets via inhibition of fatty acid synthase activity. Cell Metab. 2010;11:479-492.
31. Charo IF, Taubman MB. Chemokines in the pathogenesis of vascular disease. Circ Res. 2004;95:858-866.
32. Age-Related Eye Disease Study 2 Research Group. Lutein þ zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS) randomized clinical trial. JAMA. 2013;309:2005-2015.
33. Krinsky NI, Landrum JT, Bone RA. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Ann Rev Nutr. 2003;23:171-201.
34. Khachik F, Bernstein PS, Garland DL. Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest Ophthalmol Vis Sci. 1997;38:1802-1811.
35. Jonasson F, Fisher DE, Eiriksdottir G, et al. Five-year incidence, progression, and risk factors for age-related macular degeneration: the age, gene/environment susceptibility study. Ophthalmology. 2014;121:1766-1772.
36. Delcourt C, Michel F, Colvez A, et al. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthalmic Epidemiol. 2001;8:237-249.
37. Munch IC, Linneberg A, Larsen M. Precursors of age-related macular degeneration: associations with physical activity, obesity, and serum lipids in the inter99 eye study. Invest Ophthalmol Vis Sci. 2013;54:3932-3940.
38. Klein R, Cruickshanks KJ, Nash SD, et al. The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol. 2010;128:750-758.
39. Neuner B, Komm A, Wellmann J, et al. Smoking history and the incidence of age-related macular degeneration-results from the Muenster Aging and Retina Study (MARS) cohort and systematic review and meta-analysis of observational longitudinal studies. Addict Behav. 2009;34:938-947.
40. Albanes D, Jones DY, Micozzi MS, Mattson ME. Associations between smoking and body weight in the US population: analysis of NHANES II. Am J Public Health. 1987;77:439-444.
41. Gordon T, Kannel WB, Dawber TR, McGee D. Changes associated with quitting cigarette smoking: the Framingham Study. Am Heart J. 1975;90:322-328.
42. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults. JAMA. 2012;307:491-497.
43. Klein R, Klein BE, Knudtson MD, Meuer SM, Swift M, Gangnon RE. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology. 2007;114:253-262.
44. Rimm EB, Stampfer MJ, Colditz GA, et al. Validity of selfreported waist and hip circumferences in men and women. Epidemiology. 1990;1:466-473.